Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Intraperitoneal Chemotherapy for Ovarian Cancer
Median overall survival was 15.9 months longer among women who received intraperitoneal therapy than among those who received only standard IV therapy.
Sign In
Don't yet have a username or password?
Register now for
Journal Watch e-mail alerts and unlimited online
access to articles 6 months after publication.
Subscribe now for
Full, immediate online access to all Journal Watch content and services.
Already a subscriber? Activate your subscription to receive full online access.
Get full site access with a 7-day site pass for $19